Keisuke Taniuchi, President of our company, made a presentation on “Establishment of Human Pancreatic Cancer Organoid Transplantation Mice with Superior Drug Efficacy Evaluation” at the workshop of the 54th Annual Meeting of the Japanese Pancreatic Association held in Fukuoka, Japan on July 21-22, 2023. He reported that pancreatic cancer tissues of human pancreatic cancer organoid transplanted mice formed abundant cancer stroma and excelled in the evaluation of drug efficacy.